Best Cancer Risk Reduction Podcasts (2025)

🎧 Treating Hashimoto’s Beyond Medication with Endocrinologist Dr. Roehnelt Are your labs “normal” but you still feel off? You’re not crazy and you’re definitely not alone. In this episode of Hashimoto’s Nutrition Rx®, I’m joined by holistic endocrinologist Dr. Alessia Roehnelt, MD to break down what traditional medicine often misses about treating …

1
Stand By She: Allison Applebaum 39:37

Play Pause

1d ago39:37

39:37

EPISODE DESCRIPTION Allison Applebaum was supposed to become a concert pianist. She chose ballet instead. Then 9/11 hit, and she ran straight into a psych ward—on purpose. What followed was one of the most quietly revolutionary acts in modern medicine: founding the country’s first mental health clinic for caregivers. Because the system had decided …

1
Xiuning Le MD PhD; ESMO 2025: Sevabertinib Success for Patients with HER2-Mutated Non-Small Cell Lung Cancer in SOHO-01 Study

4d ago

—

An interview with: Xiuning Le MD PhD, Medical Oncologist, Department of Thoracic Medicine, UT MD Anderson Cancer Center, Houston TX BERLIN, Germany—Mutations in the HER2 molecule can be found in a few per cent of non-small cell lung cancers, and these can now be targeted by the new drug sevabertinib that can bring benefit to patients who have the m…

1
AI in Lung Cancer Screening 33:24

4d ago33:24

33:24

This podcast episode discusses the integration of artificial intelligence (AI) in medicine, particularly in the context of lung cancer screening and management. Hosts Rebecca Priebe and Joe Spanier explore the various applications of AI, including data acquisition, clinical decision-making, and the ethical implications of AI in healthcare. They als…

1
ESMO 2025; Christof Vulsteke MD PhD: Perioperative Enfortumab Vedotin Therapy With Pembrolizumab Boosts Event-Free and Overall Survival in Platinum-Ineligible Patients with Muscle-Invasive Bladder Cancer ... 0:07

6d ago0:07

0:07

An interview with: Christof Vulsteke MD PhD, Medical Oncologist, Head of the Integrated Cancer Center Ghent, Belgium BERLIN, Germany—Patients with muscle invasive bladder who were ineligible for cisplatin chemotherapy gained large, clinically meaningful and statistically significant benefits from treatment with the antibody drug conjugate enfortuma…

1
Xichun Hu MD PhD; ESMO 2025: Antibody Drug Conjugate Trastuzumab Botidotin Outperforms Trastuzumab Emtansine in Patients with HER2-Positive Unresectable or Metastatic Breast Cancer

7d ago

—

An interview with: Xichun Hu MD PhD, Professor, Director, Department of Medical Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China BERLIN, Germany—In a head-to-head comparison of two antibody drug conjugates used to treat unresectable or metastatic breast cancer, patients treated with trastuzumab botidotin lived more than twice as …

1
Sick Days Not Included: Rebecca V. Nellis 59:04

8d ago59:04

59:04

EPISODE DESCRIPTION Rebecca V. Nellis never meant to run a nonprofit. She just never left. Twenty years later, she’s still helming Cancer and Careers after a Craigslist maternity-leave temp job turned into a lifelong mission. In this 60-minute doubleheader, we cover everything from theater nerdom and improv rules for surviving bureaucracy, to hangi…

1
Martin Wermke MD; ESMO 2025: Initial Therapy with Bi-Specific T-cell Engager Tarlatamab Promises Better Outcomes in Patients with Small Cell Lung Cancer

9d ago

—

An interview with: Martin Wermke MD, TU Dresden, NCT/UCC Early Clinical Trial Unit and Medical Clinic, Poliklinik I, Natural Centre for Tumor Diseases, Dresden, Germany BERLIN, Germany—The prospect of markedly better outcomes for patients with small cell lung cancer, with “encouraging initial survival outcomes”, was raised by findings from the DeLL…

1
John P. Crown MD MBA: ESMO 2025, Berlin: Adjuvant Ribociclib Brought Longer Freedom from Metastases for Patients with HR+/HER2- Early Breast Cancer: NATALEE Five Year Outcomes

12d ago

—

An interview with: John P. Crown MD MBA, Consultant Medical Oncologist, St. Vincent’s University Hospital, Dublin, Professor of Translational Cancer Research, Dublin City University, Professor of Medicine, University College Dublin Ireland. BERLIN, Germany—Patients with high-risk node-negative ER-positive HER2-negative early breast cancer who had t…

1
Javier C Cortés MD PhD: ESMO 2025, Berlin: Initial Therapy with Sacituzumab Govitecan Improves Progression-Free Survival in Patients with Newly-Diagnosed Metastatic Triple Negative Breast Cancer—ASCENT ...

13d ago

—

An interview with: Javier C Cortés MD PhD, Breast Cancer Medical Oncologist, IOB Madrid, Institute of Oncology, Madrid, and International Breast Cancer Centre, Barcelona, Spain BERLIN, Germany—Treatment with the antibody drug conjugate (ADC) sacituzumab govitecan (that targets the Trop-2 cancer-associated protein, delivering a cytotoxic topoisomera…

1
Raising the Bar for PAH Treatment: Treating to Low Risk 24:27

13d ago24:27

24:27

Send us a text Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com Follow us on: Instagram @pulmapps Twitter@pulmapp Facebook @association of pulmonary advance practice providers.…

1
Dizziness, Vertigo, Migraines & Hashimoto’s: The Missing Link with Dr. Emily Kostelnik 52:40

13d ago52:40

52:40

🎙️ Dizziness, Vertigo, Migraines & Hashimoto’s: The Missing Link with Dr. Emily Kostelnik Ever feel floaty, dizzy, lightheaded—or struggle with migraines that no one seems to take seriously? You're not alone, and it may not be “just stress” or “low blood sugar.” In this eye-opening episode of Hashimoto’s Nutrition Rx, Nataliia sits down with Dr. Em…

1
GenX Therapy With Sally Wolf 41:12

15d ago41:12

41:12

Sally Wolf is back in the studio and this time we left cancer at the door. She turned 50, brought a 1993 Newsday valedictorian article as a prop, and sat down with me for a half hour of pure Gen X therapy. We dug into VHS tracking, Red Dawn paranoia, Michael J. Fox, Bette Midler, and how growing up with no helmets and playgrounds built over concret…

1
Standard Deviation EP2: Domino Effect 10:43

20d ago10:43

10:43

Dr. Nikki Maphis didn’t just lose a grant. She lost a lifeline. An early-career Alzheimer’s researcher driven by her grandmother’s diagnosis, Nikki poured years into her work—only to watch it vanish when the NIH’s MOSAIC program got axed overnight. Her application wasn’t rejected. It was deleted. No feedback. No score. Just gone. In this episode, O…

1
Family Reach: The Charity America Forced Into Existence 40:59

22d ago40:59

40:59

Carla Tardif has spent 17 years as the CEO of Family Reach, a nonprofit that shouldn’t have to exist but absolutely does—because in America, cancer comes with a price tag your insurance doesn’t cover. We talk about shame, fear, burnout, Wegmans, Syracuse, celebrity telethons, and the godforsaken reality of choosing between food and treatment. Carla…

1
Trevor Leong MD: Operable Gastric or GE-Junction Adenocarcinoma: No Advantage from Neoadjuvant Radiotherapy

22d ago

—

An interview with: Trevor Leong MD, Peter McCallum Cancer Centre, Radiation Oncology Department, Melbourne, Australia BARCELONA, Spain—Although pre-operative radiotherapy brought better response rates in patients resected for their gastric or GE-junction adenocarcinomas, there was no improvement in survival. This is the clear finding from a big, lo…

1
FAQ: How does aggressive after load reduction in PAH contribute to RV reverse remodeling & improved clinical outcomes 6:24

27d ago6:24

6:24

Send us a text Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com Follow us on: Instagram @pulmapps Twitter@pulmapp Facebook @association of pulmonary advance practice providers.…

1
The Genes of Wrath: Jennifer J. Brown 40:46

28d ago40:46

40:46

1
Slow Metabolism, GLP-1s, and Peptides: What Actually Works (and What Doesn’t) 45:18

29d ago45:18

45:18

🎙️ Slow Metabolism, GLP-1s, and Peptides: What Actually Works and What Doesn’t with Dr. Spencer Nadolsky Have you ever been told your metabolism is “slow” or wondered if GLP-1s like Ozempic or peptides like NAD+ and BPC-157 could support your Hashimoto’s healing? In this episode of Hashimoto’s Nutrition Rx, Nataliia is joined by Dr. Spencer Nadolsk…

1
James Larkin FRCP, PhD: CheckMate 067 Study 10-Year Data Show Advanced Melanoma Landscape Transformed by Combo Checkpoint Inhibitor Therapy 14:58

1M ago14:58

14:58

An interview with: James Larkin FRCP, PhD, Medical Oncologist, Professor, Royal Marsden Hospital, London Checkpoint inhibitor therapy for advanced melanoma has achieved sustained responses and long-term overall survival, transforming the prognosis for as many as half of all patients. 10-year survival outcomes from the phase Ill CheckMate 067 trial …

1
31: Weekly Dose Podcast: Arrhythmias as Early Risk Markers, Flu Vaccine Safety, Salt Substitute Use, Preconception CT Risks, and Global Diabetes Care Gaps 3:48

1M ago3:48

3:48

By Medical Economics Pulse

1
Introducing Standard Deviation EP1: The Impossible Climb 9:33

1M ago9:33

9:33

This episode of Standard Deviation features Oliver Bogler in conversation with Dr Na Zhao, a cancer biologist caught in the crossfire of science, politics, and survival. Na’s life reads like a brutal lab experiment in persistence. She grew up in China, lost her mother and aunt to breast cancer before she turned twelve, then came to the United State…

1
Jefferson DeKloe BSc: Big US Study Confirms Benefit of HPV Vaccination for Boys as Well as Girls 6:07

1M ago6:07

6:07

An interview with: Jefferson DeKloe BSc, Department of Otolaryngology, Thomas Jefferson University, Philadelphia, PA CHICAGO, USA—Although the take-up of vaccination for human papilloma virus (HPV) among girls and boys in the USA has been lower than in many other industrial countries, American researchers have now shown clearly that in addition to …

1
Rebecca Dent MD: ESMO Previous Highlights: Neo-Adjuvant Therapy for Triple Negative Breast Cancer, Checkpoint Inhibition, AI, Cancer Vaccines, and More …… 13:13

1M ago13:13

13:13

An interview with Rebecca Dent MD, Deputy Chief Executive Officer, National Cancer Centre, Singapore, ESMO 2024 Scientific Chair. ESMO Previous Highlights: Neo-Adjuvant Therapy for Triple Negative Breast Cancer, Checkpoint Inhibition, AI, Cancer Vaccines, and More ……” BARCELONA, Spain—At the last Annual Meeting of the European Society for Medical O…

1
Sorry, Your Awareness Campaign is Showing 43:22

1M ago43:22

43:22

Katie Henry has seen some things. From nonprofit bootstraps to Big Pharma boardrooms, she’s been inside the machine—and still believes we can fix it. We go deep on her winding road from folding sweaters at J.Crew to launching a vibrator-based advocacy campaign that accidentally changed the sexual health narrative in breast cancer. Katie doesn’t pul…

1
ILD in Scleroderma 35:18

1M ago35:18

35:18

In this episode of the APAPP podcast, Corinne Young hosts Amanda Mixon and Jessica Glennie to discuss scleroderma and its relationship with interstitial lung disease (ILD). They explore the identification, diagnosis, and treatment of scleroderma, emphasizing the importance of collaboration between rheumatology and pulmonary specialists. The convers…

1
Bart Neyns MD PhD: Patients with Recurrent Glioblastoma Lived Markedly Longer in Phase 1 Study of Intracranial Autologous Myeloid Dendritic Cell Therapy 10:55

1M ago10:55

10:55

Audio Journal of Oncology interview with: Bart Neyns MD PhD, Vrije Universiteit Brussel, Faculty of Medicine and Pharmacy, Medical Oncology Department, Brussels, Belgium BARCELONA, Spain—Intracranial administration of autologous dendritic cells was combined with combination checkpoint inhibition in a phase 1 study of patients with recurrent gliobla…

1
30: Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and CVD Outcomes 4:21

1M ago4:21

4:21

In this episode of the Weekly Dose podcast by Patient Care Online, we review recent studies on key clinical topics: the heightened risk of depression after chronic illness diagnosis, the safety of vaginal estradiol for women with prior stroke, the approval of generic liraglutide for obesity, the potential cancer risk reduction with GLP-1 therapies,…

1
Victor Velculescu MD PhD: Ovarian Cancer Noninvasive Detection by Circulating DNA Fragmentome and Protein Biomarker AI Analysis 13:33

1M ago13:33

13:33

An interview with: Victor Velculescu MD PhD, Co-director, Cancer Genetics & Epigenetics Program, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. SAN DIEGO, USA—A blood test using an artificial intelligence DNA pattern recognition system that brings earlier, more certain detection of o…

1
The Missing Link in Hashimoto’s Healing: Light, Mitochondria & Circadian Rhythm with Carrie Bennett 47:49

1M ago47:49

47:49

🎙️ The Missing Link in Hashimoto’s Healing: Light, Mitochondria & Circadian Rhythm with Carrie Bennett Still tired, foggy, or inflamed, even with clean eating and supplements? You might be missing the key to healing: light, circadian rhythm, and mitochondria! In this episode, Nataliia Sanzo, RD, LDN, and Carrie Bennett, MS reveal how your light env…

1
The Uncensored, Unapologetic Olivia Battinelli 42:55

1M ago42:55

42:55

What happens when you hand a mic to the most extroverted, uncensored Gen Z career coach in New York? You get Olivia Battinelli—adjunct professor, student advisor, mentor, speaker, and unfiltered truth-teller on everything from invisible illness to resume crimes. We talked about growing up Jewish-Italian in Westchester, surviving the Big Four’s corp…

1
Timothy Yap MD PhD MBBS: Selective PARP1 Inhibitor Saruparib Clinical Promise in Solid Tumors with Homologous Recombination Repair Deficiency 18:45

1M ago18:45

18:45

Audio Journal of Oncology: Sept 23rd, 2025 An interview with: Timothy Yap MD PhD MBBS, Professor of Investigational Cancer Therapeutics, Head of Clinical Development, Therapeutics Discovery Division, University of Texas MD Anderson Cancer Center, Houston, USA SAN DIEGO, USA—Breast, ovarian, pancreatic, prostate and other solid tumors with mutations…

1
Advancing ILD & PH-ILD Care 21:34

1M ago21:34

21:34

Live from APAPP 2025 in Nashville! Join Jessica Glennie and Lori Reed as they discuss advancing ILD & PH-ILD care. Send us a text Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com Follow …

1
COPD Symposium Review 17:11

1M ago17:11

17:11

Live from APAPP 2025 in Nashville! Join Tyler Kuhk and Justine Sicari discuss the highlights from the COPD symposium. Send us a text Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com Foll…

1
Acute Hypertensive Crisis for the ICU provider 35:14

1M ago35:14

35:14

Join Lora Lonidier and Rhea Voltipka as they discuss the identification and management of Acute Hypertensive Crisis. Send us a text Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com Follo…

1
Stacey Kenfield ScD and June Chan ScD: Prostate Cancer Management: New Evidence of Big Benefit from Exercise: 10:28

2M ago10:28

10:28

Interviews with: Stacey A. Kenfield ScD, Epidemiologist, Professor of Urology, Epidemiology and Biostatistics, and June Chan ScD, Cancer Epidemiologist, Department of Epibiostat and Urology, University of California San Francisco, California USA. SAN DIEGO, USA—Physical exercise keeps patients with prostate cancer alive longer, according to a combi…

1
Jonathan T. Yang MD PhD: Radiosensitizer Shows Early Clinical Promise to Support Glioblastoma Radiotherapy 10:59

2M ago10:59

10:59

An interview with Jonathan T. Yang MD PhD, Washington University, Seattle, USA, (Formerly of Memorial Sloan Kettering Cancer Center, New York.) SAN DIEGO, USA—An international phase one clinical study has found that a drug known to inhibit DNA damage repair was able to boost the efficacy of radiotherapy in patients being treated for their glioblast…

1
29: Weekly Dose Podcast: Cervical Cancer Disparities, HPV Awareness Gaps, Depression Risk After Diagnosis, PharmFIT Preferences, and Semaglutide for MASH 4:36

2M ago4:36

4:36

By Medical Economics Pulse

1
Heather McArthur MD MPH: Adjuvant Checkpoint Inhibition: Did Not Improve Survival in Patients with Triple-Negative Breast Cancer 10:06

2M ago10:06

10:06

An interview with: Heather McArthur MD MPH, Clinical Director Breast Cancer, Komen Distinguished Chair Clinical Breast Research, University of Texas Southwestern Medical Center, Dallas TX MILAN, Italy—Adjuvant therapy with a checkpoint inhibitor did not benefit patients with triple negative breast cancer in a big new study reported to the 14th Euro…

1
Stefan Paepke MD: An End to “Jumping Breasts” with Mesh Supported Pre-Pectoral Breast Implants 10:48

2M ago10:48

10:48

An interview with: Stefan Paepke MD, Interdisciplinary Breast Centre, Technical University of Munich, Germany, recorded at the 14th European Breast Cancer Conference, Milan, Italy. MILAN, Italy—Women who need surgical implants after their mastectomy for breast cancer could now benefit from mesh-supported prosthetics that bring high rates of satisfa…

1
Miss Diagnosed: Sophie Sargent 43:24

2M ago43:24

43:24

Sophie Sargent walked into the studio already owning the mic. A pandemic-era media rebel raised in New Hampshire, trained in Homeland Security (yep), and shaped by rejection, she’s built a career out of DM’ing her way into rooms and then owning them. At 25, she’s juggling chronic illness, chronic overachievement, and a generation that gets dismisse…

1
Sophie Bosma MD PhD:“Young Boost” Trial Finds Low-Dose Radiation Boost Optimal for Young Patients with High-Risk Early Breast Cancer 8:46

2M ago8:46

8:46

An interview with Sophie Bosma MD PhD, from The Netherlands Cancer Institute, Amsterdam recorded at the 14th European Breast Cancer Conference in Milan. MILAN, Italy—The optimal radiation boost dose to protect young patients with early breast cancer has been investigated with ten years of follow up in the “Young Boost trial” conducted in the Nether…

1
Adri Voogd PhD: Ductal Carcinoma in Situ: Good Outcomes from Breast Conserving Therapy, but Benefits, Risks, Costs Still Need to be Optimized 15:54

2M ago15:54

15:54

An interview with: Adri Voogd PhD, Associate Professor of Clinical Epidemiology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands MILAN, Italy—Although outcomes following breast conserving surgery (with or without radiotherapy) for ductal carcinoma in situ (DCIS) are excellent, it is still not clear …

1
Annemiek van Hemert MD PhD: “Breast Cancer: MARI Node Marker Helps Most Patients with Extensive Nodal Disease Safely Avoid Axillary Lymph Node Dissection” 10:16

2M ago10:16

10:16

An interview with Annemiek van Hemert MD PhD, Surgical Oncology Department, Antoni van Leeuwenhoek-Netherlands Cancer Institute (AVL-NKI), Amsterdam Netherlands MILAN, Italy—Four out of five patients with extensive nodal spread of their breast cancer could be spared extensive axillary dissection, if a new method of marking lymph nodes is used. That…

1
Tim Rattay MBChB PhD: Artificial Intelligence Tool Minimizes Arm Lymphedema After Breast Cancer Surgery and Radiotherapy 14:05

2M ago14:05

14:05

An interview with: Tim Rattay MBChB PhD, Consultant Breast Surgeon, University Hospitals of Leicester, Associate Professor in Breast Surgery, Leicester Cancer Research Centre, University of Leicester, England, UK. A report from the 14th European Breast Cancer Conference, Milan, Italy MILAN, Italy—An artificial intelligence tool can predict the risk…

1
Could Gut Infections Be Causing Your Painful Periods? Iron, H. Pylori & Hashimoto’s Explained 48:47

2M ago48:47

48:47

🎧 Could Gut Infections Be Causing Your Painful Periods? Iron, H. Pylori & Hashimoto’s Explained Are your labs “normal,” but you still feel off? In this powerful episode of Hashimoto’s Nutrition Rx®, Nataliia Sanzo, RD, LDN sits down with functional nutritionist Meg Langston, FNTP, RWP, RCPC, to uncover the root causes behind hormone imbalance inclu…

1
Connecting Fetal Alcohol Spectrum Disorder Education to the General Public with Lauren Borchert 25:34

2M ago25:34

25:34

In this episode, Sara and Morgan sit down Lauren Borchert, Program Manager & Certified Proof Alliance Trainer to discuss Proof Alliance NC’s work to spread the word about fetal alcohol spectrum disorder (FASD) to the public and fill the knowledge gaps, especially among women who are or will become pregnant. Listeners will gain insights into the cau…

1
Building Tools, Not Excuses: Rethinking Healthcare with Marc Elia 37:45

2M ago37:45

37:45

This episode is sponsored by Invivyd, Inc. Marc Elia is a biotech investor, the Chairman of the Board at Invivyd, and a Long COVID patient who decided to challenge the system while still stuck inside it. He’s not here for corporate platitudes, regulatory shoulder shrugs, or vaccine-era gaslighting. This is not a conversation about politics, but it'…

1
Yasmin Civil MD PhD: Low-Risk ER+ Breast Cancer: ABLATIVE Trial Finds Marked Benefit from MRI-Guided Single-Dose Neoadjuvant Partial Breast Radiotherapy 9:13

2M ago9:13

9:13

An interview with Yasmin Civil MD PhD, UMC Hospital, Amsterdam, Netherlands. MILAN, Italy—Offering MRI-guided partial breast irradiation before surgery to patients with low-risk breast cancer could become the norm, according to Yasmin Civil MD PhD from the UMC Hospital in Amsterdam, who reported five-year results from the ABLATIVE trial of pre-oper…